ImmunoKey is pioneering next-generation CAR T-cell therapies to overcome the challenges of successfully treating solid tumours. https://www.immunokey.co.uk/
| Website | http://www.immunokey.co.uk |
| Employees | 8 (6 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
Looking for a particular ImmunoKey employee's phone or email?
Gray Kueberuwa is the CEO of ImmunoKey.
6 people are employed at ImmunoKey.